Figure 2: Percentage of Patients With 35% and 50% Reduction in FIAS and TCS

Figure 2 % patients with 35% or 50% reductions

Percentage of Patients With 35% and 50% Reduction in FIAS and TCS by Time Point, Patients With FIAS and/or TCS at Baseline

Format

PNG

Source

Zynerba Pharmaceuticals, Inc.

Téléchargements